This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Articles

Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? Hints From the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a Large Naturalistic Study

Adriane R. Rosa, PharmD, PhD; Nùria Cruz, MD; Carolina Franco, MD; Josep Maria Haro, MD; Jordan Bertsch, PhD; Catherine Reed, MSc; Trond F. Aarre, MD; Jose Sanchez-Moreno, PsyD; and Eduard Vieta, MD, PhD

Published: March 23, 2010

Article Abstract

Objective: Antidepressants are supposed to be withdrawn during a manic episode. The aim of this study was to analyze the characteristics of manic patients who received antidepressants during a manic phase in a large, naturalistic study.

Method: The European Mania in Bipolar Longitudinal Evaluation of Medication was a 2-year prospective observational study of inpatients and outpatients with acute mania/mixed mania (DSM-IV or ICD-10 criteria) conducted in 14 European countries. Of 2,416 manic patients who continued into the maintenance phase of the study, 345 (14%) were taking an antidepressant and 2,071 (86%) were not taking an antidepressant at baseline, week 1, and/or week 2 postbaseline. Demographic and clinical variables were collected at baseline and each study visit up to 24 months. Outcome measures included the Clinical Global Impressions-Bipolar Disorder scale (CGI-BP overall, mania, and depression scores) at 12 weeks and 24 months, the 5-item Hamilton Depression Rating Scale (HDRS-5), and the Young Mania Rating Scale (YMRS) at 12 weeks only. The present study was conducted from December 2002 to June 2004.

Results: More antidepressant maintenance use was seen in patients with mixed episodes (P‘ ‰<‘ ‰.001), rapid cyclers (P‘ ‰<‘ ‰.02), patients with more previous depressive episodes (P‘ ‰<‘ ‰.001), and patients with higher mean HDRS-5 score at baseline (P‘ ‰<‘ ‰.001)—specifically patients with anxiety (P‘ ‰=‘ ‰.013). Patients in the antidepressant group had significantly higher CGI-BP depression scores (P‘ ‰<‘ ‰.001) and a significantly higher rate of depression relapse (P‘ ‰<‘ ‰.001) at both 12 weeks and 24 months.

Conclusions: Patients with mania receiving antidepressants are more likely to be outpatients with mixed episodes, anxiety, or rapid cycling and have a higher risk of depression relapse during follow-up.

J Clin Psychiatry 2010;71(8):1000-1006

Submitted: January 8, 2009; accepted March 6, 2009.

Online ahead of print: March 23, 2010 (doi:10.4088/JCP.09m05026gre).

Corresponding author: Eduard Vieta, MD, PhD, Clinical Institute of Neuroscience, University Clinic Hospital of Barcelona, Villarroel 170, 08036-Barcelona, Spain (evieta@clinic.ub.es and evieta@mclean.harvard.edu).

Volume: 71

Quick Links: Bipolar Disorder

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...